Biology D Even
Caroline Schetlick
Works Cited
Pollack,
Andrew. "Hepatitis C, a Silent Killer, Meets Its Match." New York
Times. New York Times, 4 Nov. 2013. Web. 7 Nov. 2013.
<http://www.nytimes.com/2013/11/05/health/hepatitis-c-a-silent-killer-meets-its-match.html?hpw&rref=science>.
There have been many experiments
attempting to discover a medicinal cure for Hepatitis C, a deadly virus
transmitted through the use of needles and occasionally sex. Hepatitis C can
lead to severe liver damage or scarring of the liver, also known as cirrhosis,
and liver cancer. Dr. Arthur Rubens, a professor of management at Florida Gulf
Coast University, was striving to find a cure for his Hepatitis C infection
that was gradually destroying his own liver. He continued trying treatment
after treatment to try and solve this problem, however none of them worked and
only led to horrible side effects, such as insomnia, depression, fever, anemia,
and a burning rash. In spite of that, Dr. Rubens engaged in a clinical trial to
test new pills against the virus. Taking the pill was easy and the virus was
vanished after three months of treatment. Research has shown that Hepatitis C
kills more Americans a year than AIDS and is the main cause of liver cancer and
transplants. With this in mind, new drugs for this “silent plague” will be
coming to markets in the next three years that will help victims of this virus
in as little as eight weeks with few side effects. Despite that, the new drugs
will cost $60,000 to over $100,000 for treatment, making access to the drug a
problem, specifically for the uninsured and in developing countries.
Differentiating from HIV, a patient taking these drugs will not have to take
them for life. Once the virus is out of his system, he will no longer need to take
the drug, whereas HIV victims need to take medication and treatment for life. Having
said that, people are still at risk of liver cancer if the virus infected them.
This positive energy is a new booster for the research and science world
because the previous testing on these pills did not bring the results wanted.
With this new drug, it impedes the enzyme of the virus and builds genomes out
of the RNA, and the virus can replicate. But, the enzyme produces is somewhat
like a decoy so the RNA cannot reproduce a chain, therefore stopping the virus.
This was an amazing discovery and a very large step for Hepatitis C patients.
This article definitely has a large
affect on Americans, having said that four million have been infected with
Hepatitis C. This article doesn’t only affect Americans, but people worldwide. Hepatitis
C has negatively impacted the lives of 150 million people and counting. The
discovery of this new pill can be a great thing if scientists figure out an
easier way to distribute and find a better cost so it can be financially
appealing to all. The fact that someone was capable of creating a “fake” enzyme
to somewhat “trick” the virus is simply remarkable. I am truly amazed at the
level of complexity scientists can test to today with the use of technology and
extreme use of knowledge. This article stuck out to me out of all of the
biology articles in particular, mainly because the science of medicine
interests me and I love learning about new research and new ideas coming
through in the world. I had not really heard of Hepatitis C previously, but I
now realize what an impact this virus has made on so many lives. It is
astounding, and quite frankly sad. But, things are looking up with this new
medication.
This article was very well written
and easy to understand, however very lengthy. The author included many details,
maybe too many. In addition, he included large scientific vocabulary in the
beginning of the article, which was hard to follow because I had absolutely no idea
what he was talking about until the next page where he then explains what the
virus is, the side effects, long-term effects, and more. Pollack’s tone of
voice in this article really pulled the reader in, creating a want to read
more. Overall, a great piece that was very interesting and insightful.
No comments:
Post a Comment